Effectiveness of Dextrose Injection for Osgood-Schlatter Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2010

Conditions
Osgood-Schlatter Disease
Interventions
PROCEDURE

Dextrose Injection

12.5 Dextrose in 1% Lidocaine injected monthly for 3 months with a 27 gauge needle on painful areas of the tibial tuberosity, under the patellar tendon.

PROCEDURE

Lidocaine Injection

1% Lidocaine injected monthly for 3 months with a 27 gauge needle on painful areas of the tibial tuberosity, under the patellar tendon.

OTHER

Usual Care

Therapist supervised exercises that are standard of care for Osgood-Schatter Disease as well as relative rest and gradual resumption of pain-limited sport.

Trial Locations (1)

Unknown

Hospital Provincial de Rosario, Rosario

All Listed Sponsors
lead

Universidad Nacional de Rosario

OTHER

NCT01300754 - Effectiveness of Dextrose Injection for Osgood-Schlatter Disease | Biotech Hunter | Biotech Hunter